JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
QUICK SEARCH:   [advanced]


     

J Am Coll Cardiol, 1998; 32:360-367
© 1998 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barron, H. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barron, H. V.

Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States: data from the National Registry of Myocardial Infarction 2

Hal V. Barron, MD, FACC* {dagger}, Andrew D. Michaels, MD*, Charles Maynard, PhD{ddagger}, Nathan R. Every, MD, MPH{ddagger} for the National Registry of Myocardial Infarction 2 Participants§

* Department of Medicine, Division of Cardiology, University of California–San Francisco Medical Center, San Francisco, California, USA
{dagger} Genentech, Inc., South San Francisco, California, USA
{ddagger} Myocardial Infarction Triage and Intervention (MITI) Coordinating Center, Seattle, Washington, USA



View larger version (24K):

[in a new window]
  		Figure 1 Discharge ACE inhibitor use by clinical indication group.

 


View larger version (11K):

[in a new window]
  		Figure 2 Discharge ACE inhibitor (squares) and calcium channel blocker (circles) use by time period.

 




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 1998 by the American College of Cardiology Foundation.